Kane S - Search Results

1

Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes.

Koliani-Pace JL, Singh S, Luo M, Hirten R, Aniwan S, Kochhar G, Chang S, Lukin D, Gao Y, Bohm M, Swaminath A, Gupta N, Shmidt E, Meserve J, Winters A, Chablaney S, Faleck DM, Yang J, Huang Z, Boland BS, Shashi P, Weiss A, Hudesman D, Varma S, Fischer M, Sultan K, Shen B, Kane S, Loftus EV, Sands BE, Colombel JF, Sandborn WJ, Lasch K, Siegel CA, Dulai PS. Koliani-Pace JL, et al. Among authors: kane s. Inflamm Bowel Dis. 2019 Oct 18;25(11):1854-1861. doi: 10.1093/ibd/izz071. Inflamm Bowel Dis. 2019. PMID: 31050734 Free PMC article.

2

The effectiveness of budesonide therapy for Crohn's disease.

Kane SV, Schoenfeld P, Sandborn WJ, Tremaine W, Hofer T, Feagan BG. Kane SV, et al. Aliment Pharmacol Ther. 2002 Aug;16(8):1509-17. doi: 10.1046/j.1365-2036.2002.01289.x. Aliment Pharmacol Ther. 2002. PMID: 12182751 Review.

3

Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.

Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB. Kane SV, et al. Am J Gastroenterol. 2003 Jun;98(6):1309-14. doi: 10.1111/j.1572-0241.2003.07458.x. Am J Gastroenterol. 2003. PMID: 12818275

4

Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.

Loftus EV Jr, Kane SV, Bjorkman D. Loftus EV Jr, et al. Among authors: kane sv. Aliment Pharmacol Ther. 2004 Jan 15;19(2):179-89. doi: 10.1111/j.0269-2813.2004.01827.x. Aliment Pharmacol Ther. 2004. PMID: 14723609 Review.

5

An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease.

Sandborn WJ, Hanauer S, Loftus EV Jr, Tremaine WJ, Kane S, Cohen R, Hanson K, Johnson T, Schmitt D, Jeche R. Sandborn WJ, et al. Among authors: kane s. Am J Gastroenterol. 2004 Oct;99(10):1984-9. doi: 10.1111/j.1572-0241.2004.40462.x. Am J Gastroenterol. 2004. PMID: 15447761 Clinical Trial.

6

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease.

Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Mahadevan U, et al. Among authors: kane s. Aliment Pharmacol Ther. 2005 Mar 15;21(6):733-8. doi: 10.1111/j.1365-2036.2005.02405.x. Aliment Pharmacol Ther. 2005. PMID: 15771759 Review.

7

Possible association between isotretinoin and inflammatory bowel disease.

Reddy D, Siegel CA, Sands BE, Kane S. Reddy D, et al. Among authors: kane s. Am J Gastroenterol. 2006 Jul;101(7):1569-73. doi: 10.1111/j.1572-0241.2006.00632.x. Am J Gastroenterol. 2006. PMID: 16863562

8

Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California.

Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Mahadevan U, et al. Among authors: kane s. Gastroenterology. 2007 Oct;133(4):1106-12. doi: 10.1053/j.gastro.2007.07.019. Epub 2007 Jul 25. Gastroenterology. 2007. PMID: 17764676

9

Disease perceptions among people with Crohn's disease.

Kane SV, Loftus EV Jr, Dubinsky MC, Sederman R. Kane SV, et al. Inflamm Bowel Dis. 2008 Aug;14(8):1097-101. doi: 10.1002/ibd.20418. Inflamm Bowel Dis. 2008. PMID: 18338774

10

Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey.

Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, Loftus EV, Hopper J. Rubin DT, et al. Inflamm Bowel Dis. 2009 Apr;15(4):581-8. doi: 10.1002/ibd.20793. Inflamm Bowel Dis. 2009. PMID: 19067414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,334 results

Search Page

Filters